BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24005314)

  • 1. Genetic variation at the IGF1 locus shows association with post-stroke outcome and to circulating IGF1.
    Aberg ND; Olsson S; Aberg D; Jood K; Stanne TM; Nilsson M; Blomstrand C; Svensson J; Isgaard J; Jern C
    Eur J Endocrinol; 2013 Dec; 169(6):759-65. PubMed ID: 24005314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation at the BDNF locus: evidence for association with long-term outcome after ischemic stroke.
    Stanne TM; Tjärnlund-Wolf A; Olsson S; Jood K; Blomstrand C; Jern C
    PLoS One; 2014; 9(12):e114156. PubMed ID: 25470006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered levels of circulating insulin-like growth factor I (IGF-I) following ischemic stroke are associated with outcome - a prospective observational study.
    Åberg ND; Åberg D; Jood K; Nilsson M; Blomstrand C; Kuhn HG; Svensson J; Jern C; Isgaard J
    BMC Neurol; 2018 Aug; 18(1):106. PubMed ID: 30081862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common genetic variation in the IGF1 associates with maximal force output.
    Huuskonen A; Lappalainen J; Oksala N; Santtila M; Häkkinen K; Kyröläinen H; Atalay M
    Med Sci Sports Exerc; 2011 Dec; 43(12):2368-74. PubMed ID: 21552154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IGF-I levels correlate to improvement of functional outcome after ischemic stroke.
    Åberg D; Jood K; Blomstrand C; Jern C; Nilsson M; Isgaard J; Aberg ND
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1055-64. PubMed ID: 21508132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin activatable fibrinolysis inhibitor activation peptide shows association with all major subtypes of ischemic stroke and with TAFI gene variation.
    Ladenvall C; Gils A; Jood K; Blomstrand C; Declerck PJ; Jern C
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):955-62. PubMed ID: 17272741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the phosphodiesterase 4D (PDE4D) gene and cardioembolic stroke in an Australian cohort.
    Milton AG; Aykanat VM; Hamilton-Bruce MA; Nezic M; Jannes J; Koblar SA
    Int J Stroke; 2011 Dec; 6(6):480-6. PubMed ID: 21989204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variation within the interleukin-1 gene cluster and ischemic stroke.
    Olsson S; Holmegaard L; Jood K; Sjögren M; Engström G; Lövkvist H; Blomstrand C; Norrving B; Melander O; Lindgren A; Jern C
    Stroke; 2012 Sep; 43(9):2278-82. PubMed ID: 22744645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer.
    Johansson M; McKay JD; Stattin P; Canzian F; Boillot C; Wiklund F; Adami HO; Bälter K; Grönberg H; Kaaks R
    Int J Cancer; 2007 Feb; 120(3):539-42. PubMed ID: 17096324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in complement component C3 shows association with ischaemic stroke.
    Olsson S; Stokowska A; Holmegaard L; Jood K; Blomstrand C; Pekna M; Jern C
    Eur J Neurol; 2011 Oct; 18(10):1272-4. PubMed ID: 21414106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 gene -174 G/C promoter polymorphism predicts severity and outcome in acute ischemic stroke patients from north India.
    Chakraborty B; Chowdhury D; Vishnoi G; Goswami B; Kishore J; Agarwal S
    J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):683-9. PubMed ID: 22410655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive contribution of genetic variations of the insulin-like growth factor 1 signalling pathway to stroke susceptibility.
    Yao Y; Zhu H; Zhu L; Fang Z; Fan Y; Liu C; Tian Y; Chen Y; Tang W; Ren Z; Li J; Yang S; Chen Y; Zhao X; Shen C
    Atherosclerosis; 2020 Mar; 296():59-65. PubMed ID: 32065979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Levels of Serum Insulin-like Growth Factor I and Functional Recovery, Mortality, and Recurrent Stroke at a 7-year Follow-up.
    Åberg ND; Åberg D; Lagging C; Holmegaard L; Redfors P; Jood K; Nilsson M; Åberg M; Blomstrand C; Svensson J; Jern C; Isgaard J
    Exp Clin Endocrinol Diabetes; 2020 May; 128(5):303-310. PubMed ID: 31261410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 promoter 174 G/C polymorphisms in acute ischemic stroke: G allele is protective but not associated with IL-6 levels or stroke outcome.
    Yan J; Jm G; Pa M
    J Neuroimmunol; 2016 Apr; 293():22-27. PubMed ID: 27049557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy.
    Palles C; Johnson N; Coupland B; Taylor C; Carvajal J; Holly J; Fentiman IS; Silva Idos S; Ashworth A; Peto J; Fletcher O
    Hum Mol Genet; 2008 May; 17(10):1457-64. PubMed ID: 18250100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the insulin like growth factor 1 and IGF binding protein 3 genes and risk of colorectal cancer.
    Pechlivanis S; Wagner K; Chang-Claude J; Hoffmeister M; Brenner H; Försti A
    Cancer Detect Prev; 2007; 31(5):408-16. PubMed ID: 18031946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding.
    Maguire J; Thakkinstian A; Levi C; Lincz L; Bisset L; Sturm J; Scott R; Whyte S; Attia J
    J Stroke Cerebrovasc Dis; 2011; 20(2):134-44. PubMed ID: 20472470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly.
    Denti L; Annoni V; Cattadori E; Salvagnini MA; Visioli S; Merli MF; Corradi F; Ceresini G; Valenti G; Hoffman AR; Ceda GP
    Am J Med; 2004 Sep; 117(5):312-7. PubMed ID: 15336580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of ALOX5AP1 SG13S114T/A variant with ischemic stroke, stroke subtypes and aspirin resistance.
    Sharma V; Dadheech S; Kaul S; Jyothy A; Munshi A
    J Neurol Sci; 2013 Aug; 331(1-2):108-13. PubMed ID: 23746795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer.
    Al-Zahrani A; Sandhu MS; Luben RN; Thompson D; Baynes C; Pooley KA; Luccarini C; Munday H; Perkins B; Smith P; Pharoah PD; Wareham NJ; Easton DF; Ponder BA; Dunning AM
    Hum Mol Genet; 2006 Jan; 15(1):1-10. PubMed ID: 16306136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.